Cargando…

Pregnant people deserve the protection offered by SARS-CoV-2 vaccines

• It is imperative that vaccine development and deployment include pregnant individuals because: • They are at equal, if not greater, risk of severe COVID-19 illness than nonpregnant patients. • Vertical transmission of SARS-CoV-2 to the fetus has been documented. • Placental injury from SARS-CoV-2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maykin, Melanie M., Heuser, Cara, Feltovich, Helen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834417/ https://www.ncbi.nlm.nih.gov/pubmed/33308888 http://dx.doi.org/10.1016/j.vaccine.2020.12.007

Ejemplares similares

Venous thromboembolism deserves your attention
por: Marc Samama, Charles
Publicado: (2001)

Inactivated SARS-CoV-2 vaccine for people with HIV
por: Wolday, Dawit, et al.
Publicado: (2022)

Damage in hidradenitis suppurativa: receiving the deserved attention
por: Aarts, Pim, et al.
Publicado: (2022)

Protective measures for patients with advanced cancer during the Sars-CoV-2 pandemic: Quo vadis?
por: Ivanyi, P., et al.
Publicado: (2021)

The new WHO Foundation — global health deserves better
por: Maani, Nason, et al.
Publicado: (2021)

Increasing SARS-CoV-2 vaccination rates among Black people in Canada
por: Eissa, Azza, et al.
Publicado: (2021)

Exceptional epidemics: AIDS still deserves a global response
por: Whiteside, Alan, et al.
Publicado: (2009)

Does cancer deserve special treatment when health technologies are prioritized?
por: Hansen, Paul
Publicado: (2013)

The potential of developing a protective peptide‐based vaccines against SARS‐CoV‐2
por: Shalash, Ahmed O., et al.
Publicado: (2022)

A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection
por: Casanova, Jean-Laurent, et al.
Publicado: (2020)

IgM responses following SARS-CoV-2 vaccination: insights into protective and pre-existing immunity
por: Fraussen, Judith
Publicado: (2022)

Timely development of vaccines against SARS-CoV-2
por: Lu, Shan
Publicado: (2020)

Is there a post-SARS-CoV-2 vaccination dementia?
por: Fiorini, Ana C., et al.
Publicado: (2022)

Why Canadians deserve to have mandated health and standard drink information labels on alcohol containers
por: Giesbrecht, Norman, et al.
Publicado: (2023)

MERS Vaccine Candidate Offers Promise, but Questions Remain
por: Menachery, Vineet D.
Publicado: (2015)

Offering pre-exposure prophylaxis for HIV prevention to pregnant and postpartum women: a clinical approach
por: Seidman, Dominika L, et al.
Publicado: (2017)

Progress towards vaccines to protect pregnant women from malaria
por: Rogerson, Stephen J., et al.
Publicado: (2019)

Unanticipated efficacy of SARS-CoV-2 vaccination in older adults
por: Pawelec, Graham, et al.
Publicado: (2021)

Multicomponent vaccines to fight SARS-CoV-2 variants of concern
por: Cassone, Antonio, et al.
Publicado: (2021)

The challenge of emerging SARS-CoV-2 mutants to vaccine development
por: Li, Rong, et al.
Publicado: (2021)

SARS-CoV-2 immunogenicity: Is S protein the best target for vaccination?
por: Antonopoulou, Tania, et al.
Publicado: (2022)

Questioning the justification for a fourth SARS-CoV-2 vaccine
por: Calderon-Margalit, Ronit, et al.
Publicado: (2022)

T cells as the hoped-for savior for SARS-CoV-2 vaccination during CD20-depleting antibody therapy?: Commentary for: “Discordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy.”
por: Bsteh, Gabriel, et al.
Publicado: (2021)

SARS-CoV-2 Brazil variants in Latin America: More serious research urgently needed on public health and vaccine protection
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

Help for the Deserving
por: Lewisburg, J. H. M.
Publicado: (1876)

SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
por: Salvatori, Giovanni, et al.
Publicado: (2020)

Positive aspects of the mRNA platform for SARS-CoV-2 vaccines
por: Hajissa, Khalid, et al.
Publicado: (2021)

COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants
por: Cevik, Muge, et al.
Publicado: (2021)

SARS-CoV-2 vaccination for immune-comprised patients: More is required
por: Li, Hui, et al.
Publicado: (2021)

Detect to protect: pneumoperitoneum gas samples for SARS-CoV-2 and biohazard testing
por: Cicuttin, Enrico, et al.
Publicado: (2020)

Vaccination and protective immunity to SARS-CoV-2 omicron variants in people with immunodeficiencies
por: Nadesalingam, Angalee, et al.
Publicado: (2023)

Skin rashes after SARS‐CoV‐2 vaccine: which relationship, if any?
por: Patruno, Cataldo, et al.
Publicado: (2021)

Vaccine against SARS-CoV-2 in previously infected health care workers
por: Parisi, Saverio Giuseppe
Publicado: (2021)

Prevention and Treatment of SARS-CoV2 Infection in People Living with HIV: The Need for Specific Data
por: Díaz, Natalia A., et al.
Publicado: (2021)

Universal Screening for SARS-CoV-2 in Asymptomatic Pregnant Women: A Multi-center Experience
por: Sharma, Shreyasi, et al.
Publicado: (2021)

SARS-CoV-2 variants offer a second chance to fix vaccine inequities
por: Hotez, Peter J.
Publicado: (2022)

Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development
por: Cohen, Samuel A., et al.
Publicado: (2020)

The potential risks of delaying the second vaccine dose during the SARS-CoV-2 pandemic
por: Humphreys, I R, et al.
Publicado: (2021)

Why we may need to rethink future SARS-CoV-2 vaccination strategies
por: Klimek, Peter
Publicado: (2021)

Validation of the effectiveness of SARS-CoV-2 vaccines in older adults in “real-world” settings
por: Weng, Nan-ping, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_205lm9bsvqvpr75dr9sun1n1v9